Belarus vs Paraguay: Prevalence rate of hypertension in adults aged 30-79
Belarus
49.2
in 2019
Paraguay
56.4
in 2019
Belarus rank
3rd
Paraguay rank
1st
Prevalence rate of hypertension in adults aged 30-79 over time
- Belarus
- Paraguay
How they compare
Paraguay currently reports 56.4 against 49.2 in Belarus, a difference of 7.2.
That makes Paraguay's figure about 1.1 times Belarus's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Belarus ahead.
Belarus ranks 3rd and Paraguay ranks 1st of 194 countries.
Across the 3 decades both report, Belarus averaged higher in 1 and Paraguay in 2.
Head to head by decade
| Decade | Belarus | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 52.21 | 49.65 | 2.56 | Belarus |
| 2000s | 50.72 | 54.41 | 3.69 | Paraguay |
| 2010s | 49.76 | 56.52 | 6.76 | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Belarus or Paraguay?
- Paraguay, at 56.4 against 49.2 in Belarus as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Belarus and Paraguay?
- 7.2, with Paraguay ahead.
- How many years of comparable data are there for Belarus and Paraguay?
- 30 years are reported by both, from 1990 to 2019.
- How do Belarus and Paraguay rank globally for prevalence rate of hypertension in adults aged 30-79?
- Belarus ranks 3rd and Paraguay ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.